TreeWAS – Variant ID: rs12653117

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D25.1 Intramural leiomyoma of uterus	0.000	0.983	0.017
Z03.4 Observation for suspected myocardial infarction	0.000	0.990	0.010
I21.4 Acute subendocardial myocardial infarction	0.000	0.990	0.010
Z57 Occupational exposure to risk-factors	0.009	0.991	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.009	0.991	0.000
Z57.3 Occupational exposure to other air contaminants	0.009	0.991	0.000
Z57.2 Occupational exposure to dust	0.009	0.991	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.008	0.992	0.000
Z63 Other problems related to primary support group, including family circumstances	0.007	0.993	0.000
Z03.9 Observation for suspected disease or condition, unspecified	0.000	0.993	0.007
T43.2 Other and unspecified antidepressants	0.007	0.993	0.000
T40.2 Other opioids	0.007	0.993	0.000
Z57.9 Occupational exposure to unspecified risk-factor	0.007	0.993	0.000
Z57.8 Occupational exposure to other risk-factors	0.007	0.993	0.000
Z57.7 Occupational exposure to vibration	0.007	0.993	0.000
Z57.6 Occupational exposure to extreme temperature	0.007	0.993	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.007	0.993	0.000
Z57.1 Occupational exposure to radiation	0.007	0.993	0.000
Z57.0 Occupational exposure to noise	0.007	0.993	0.000
Z58 Problems related to physical environment	0.007	0.993	0.000
Z63.4 Disappearance and death of family member	0.007	0.993	0.000
Z63.7 Other stressful life events affecting family and household	0.006	0.993	0.000
Z03 Medical observation and evaluation for suspected diseases and conditions	0.000	0.993	0.007
Z58.1 Exposure to air pollution	0.006	0.994	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.006	0.994	0.000
Z59 Problems related to housing and economic circumstances	0.006	0.994	0.000
Z65 Problems related to other psychosocial circumstances	0.006	0.994	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.006	0.994	0.000
Z56 Problems related to employment and unemployment	0.006	0.994	0.000
W22.9 Unspecified place	0.000	0.994	0.006
Z63.0 Problems in relationship with spouse or partner	0.006	0.994	0.000
Z64 Problems related to certain psychosocial circumstances	0.006	0.994	0.000
Z62 Other problems related to upbringing	0.006	0.994	0.000
Z61 Problems related to negative life events in childhood	0.006	0.994	0.000
Z55 Problems related to education and literacy	0.006	0.994	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.006	0.994	0.000
Z63.9 Problem related to primary support group, unspecified	0.005	0.994	0.000
Z63.6 Dependent relative needing care at home	0.005	0.994	0.000
Z63.5 Disruption of family by separation and divorce	0.005	0.994	0.000
Z63.3 Absence of family member	0.005	0.994	0.000
Z63.2 Inadequate family support	0.005	0.994	0.000
Z63.1 Problems in relationship with parents and in-laws	0.005	0.994	0.000
Z03.8 Observation for other suspected diseases and conditions	0.000	0.995	0.005
Z03.2 Observation for suspected mental and behavioural disorders	0.000	0.995	0.005
Z65.8 Other specified problems related to psychosocial circumstances	0.005	0.995	0.000
Z58.9 Problem related to physical environment, unspecified	0.005	0.995	0.000
Z58.8 Other problems related to physical environment	0.005	0.995	0.000
Z58.7 Exposure to tobacco smoke	0.005	0.995	0.000
Z58.6 Inadequate drinking-water supply	0.005	0.995	0.000
Z58.5 Exposure to other pollution	0.005	0.995	0.000
Z58.4 Exposure to radiation	0.005	0.995	0.000
Z58.3 Exposure to soil pollution	0.005	0.995	0.000
Z58.2 Exposure to water pollution	0.005	0.995	0.000
Z58.0 Exposure to noise	0.005	0.995	0.000
Z59.0 Homelessness	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T40.6 Other and unspecified narcotics	0.005	0.995	0.000
Z03.6 Observation for suspected toxic effect from ingested substance	0.000	0.995	0.005
T43.5 Other and unspecified antipsychotics and neuroleptics	0.005	0.995	0.000
Z59.8 Other problems relating to housing and economic circumstances	0.005	0.995	0.000
Z03.0 Observation for suspected tuberculosis	0.000	0.995	0.005
Z63.8 Other specified problems related to primary support group	0.005	0.995	0.000
T43.9 Psychotropic drug, unspecified	0.005	0.995	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
T43.6 Psychostimulants with abuse potential	0.005	0.995	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.005	0.995	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.005	0.995	0.000
Z03.3 Observation for suspected nervous system disorder	0.000	0.995	0.005
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.005	0.995	0.000
Z59.7 Insufficient social insurance and welfare support	0.005	0.995	0.000
Z59.6 Low income	0.005	0.995	0.000
Z59.5 Extreme poverty	0.005	0.995	0.000
Z59.4 Lack of adequate food	0.005	0.995	0.000
Z59.3 Problems related to living in residential institution	0.005	0.995	0.000
Z59.2 Discord with neighbours, lodgers and landlord	0.005	0.995	0.000
Z59.1 Inadequate housing	0.005	0.995	0.000
T40.4 Other synthetic narcotics	0.005	0.995	0.000
Z56.0 Unemployment, unspecified	0.005	0.995	0.000
Z65.9 Problem related to unspecified psychosocial circumstances	0.005	0.995	0.000
Z65.5 Exposure to disaster, war and other hostilities	0.005	0.995	0.000
Z65.4 Victim of crime and terrorism	0.005	0.995	0.000
Z65.3 Problems related to other legal circumstances	0.005	0.995	0.000
Z65.2 Problems related to release from prison	0.005	0.995	0.000
Z65.1 Imprisonment and other incarceration	0.005	0.995	0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.005	0.995	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.005	0.995	0.000
T40.8 Lysergide [LSD]	0.005	0.995	0.000
T40.7 Cannabis (derivatives)	0.005	0.995	0.000
T40.5 Cocaine	0.005	0.995	0.000
T40.3 Methadone	0.005	0.995	0.000
T40.1 Heroin	0.005	0.995	0.000
T40.0 Opium	0.005	0.995	0.000
Z56.6 Other physical and mental strain related to work	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
Z56.7 Other and unspecified problems related to employment	0.004	0.995	0.000
Z56.5 Uncongenial work	0.004	0.995	0.000
Z56.4 Discord with boss and workmates	0.004	0.995	0.000
Z56.3 Stressful work schedule	0.004	0.995	0.000
Z56.2 Threat of job loss	0.004	0.995	0.000
Z56.1 Change of job	0.004	0.995	0.000
Z64.0 Problems related to unwanted pregnancy	0.004	0.995	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
Z64.4 Discord with counsellors	0.004	0.996	0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.004	0.996	0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.004	0.996	0.000
Z64.1 Problems related to multiparity	0.004	0.996	0.000
Z55.9 Problems relating to education and literacy, unspecified	0.004	0.996	0.000
Z55.8 Other problems relating to education and literacy	0.004	0.996	0.000
Z55.4 Educational maladjustment and discord with teachers and classmates	0.004	0.996	0.000
Z55.3 Underachievement in school	0.004	0.996	0.000
Z55.2 Failed examinations	0.004	0.996	0.000
Z55.1 Schooling unavailable and unattainable	0.004	0.996	0.000
Z55.0 Illiteracy and low-level literacy	0.004	0.996	0.000
Z61.9 Negative life events in childhood, unspecified	0.004	0.996	0.000
Z61.8 Other negative life events in childhood	0.004	0.996	0.000
Z61.7 Personal frightening experience in childhood	0.004	0.996	0.000
Z61.6 Problems related to alleged physical abuse of child	0.004	0.996	0.000
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.004	0.996	0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.004	0.996	0.000
Z61.3 Events resulting in loss of self-esteem in childhood	0.004	0.996	0.000
Z61.2 Altered pattern of family relationships in childhood	0.004	0.996	0.000
Z61.1 Removal from home in childhood	0.004	0.996	0.000
Z61.0 Loss of love relationship in childhood	0.004	0.996	0.000
Z62.9 Problem related to upbringing, unspecified	0.004	0.996	0.000
Z62.8 Other specified problems related to upbringing	0.004	0.996	0.000
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing	0.004	0.996	0.000
Z62.5 Other problems related to neglect in upbringing	0.004	0.996	0.000
Z62.4 Emotional neglect of child	0.004	0.996	0.000
Z62.3 Hostility towards and scapegoating of child	0.004	0.996	0.000
Z62.2 Institutional upbringing	0.004	0.996	0.000
Z62.1 Parental overprotection	0.004	0.996	0.000
Z62.0 Inadequate parental supervision and control	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.996	0.004
N32.3 Diverticulum of bladder	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.004	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
T36.0 Penicillins	0.004	0.996	0.000
T42.4 Benzodiazepines	0.004	0.996	0.000
D70 Agranulocytosis	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
Z60 Problems related to social environment	0.004	0.996	0.000
T42.1 Iminostilbenes	0.004	0.996	0.000
T42.0 Hydantoin derivatives	0.003	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.003	0.996	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.003	0.996	0.000
T42.3 Barbiturates	0.003	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.003	0.996	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.003	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T38.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
T38.7 Androgens and anabolic congeners	0.003	0.997	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
T38.5 Other oestrogens and progestogens	0.003	0.997	0.000
T38.4 Oral contraceptives	0.003	0.997	0.000
T38.2 Antithyroid drugs	0.003	0.997	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.997	0.000
T38.0 Glucocorticoids and synthetic analogues	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
N20.1 Calculus of ureter	0.003	0.997	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
D41.4 Bladder	0.000	0.997	0.003
N20.9 Urinary calculus, unspecified	0.003	0.997	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
E11.3 With ophthalmic complications	0.000	0.997	0.003
S62.60 Fracture of other finger (closed)	0.000	0.997	0.003
O72.1 Other immediate postpartum haemorrhage	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
Z03.1 Observation for suspected malignant neoplasm	0.000	0.997	0.003
W22 Striking against or struck by other objects	0.000	0.997	0.003
Z60.9 Problem related to social environment, unspecified	0.003	0.997	0.000
Z60.8 Other problems related to social environment	0.003	0.997	0.000
Z60.5 Target of perceived adverse discrimination and persecution	0.003	0.997	0.000
Z60.4 Social exclusion and rejection	0.003	0.997	0.000
Z60.3 Acculturation difficulty	0.003	0.997	0.000
Z60.1 Atypical parenting situation	0.003	0.997	0.000
Z60.0 Problems of adjustment to life-cycle transitions	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
Z03.5 Observation for other suspected cardiovascular diseases	0.000	0.997	0.003
J32.9 Chronic sinusitis, unspecified	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.997	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T50.5 Appetite depressants	0.003	0.997	0.000
T50.4 Drugs affecting uric acid metabolism	0.003	0.997	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.1 Loop [high-ceiling] diuretics	0.003	0.997	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.002	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.002	0.997	0.000
T44.0 Anticholinesterase agents	0.002	0.997	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.997	0.003
C83.3 Large cell (diffuse)	0.000	0.997	0.003
A08.4 Viral intestinal infection, unspecified	0.002	0.997	0.000
W22.8 Other specified place	0.000	0.998	0.002
W22.6 Industrial and construction area	0.000	0.998	0.002
W22.4 Street and highway	0.000	0.998	0.002
W22.0 Home	0.000	0.998	0.002
W22.7 Farm	0.000	0.998	0.002
W22.5 Trade and service area	0.000	0.998	0.002
W22.1 Residential institution	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
K31.7 Polyp of stomach and duodenum	0.000	0.998	0.002
S06.80 Other intracranial injuries (without open intracranial wound)	0.002	0.998	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.998	0.002
W22.3 Sports and athletics area	0.000	0.998	0.002
N20 Calculus of kidney and ureter	0.002	0.998	0.000
W22.2 School, other institution and public administrative area	0.000	0.998	0.002
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
J32 Chronic sinusitis	0.000	0.998	0.002
J32.8 Other chronic sinusitis	0.000	0.998	0.002
C92.1 Chronic myeloid leukaemia	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
I42.0 Dilated cardiomyopathy	0.000	0.998	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.998	0.002
O82.0 Delivery by elective Caesarean section	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
D25 Leiomyoma of uterus	0.000	0.998	0.002
W22.09 Striking against or struck by other objects; Home; During unspecified activity	0.000	0.998	0.002
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work	0.000	0.998	0.002
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity	0.000	0.998	0.002
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income	0.000	0.998	0.002
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities	0.000	0.998	0.002
Q24.8 Other specified congenital malformations of heart	0.002	0.998	0.000
D25.2 Subserosal leiomyoma of uterus	0.000	0.998	0.002
C92 Myeloid leukaemia	0.000	0.998	0.002
D70-D77 Other diseases of blood and blood-forming organs	0.000	0.998	0.002
D11.0 Parotid gland	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.000	0.998	0.002
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.001	0.998	0.001
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.001	0.998	0.000
J32.3 Chronic sphenoidal sinusitis	0.000	0.998	0.002
J32.1 Chronic frontal sinusitis	0.000	0.998	0.002
D75 Other diseases of blood and blood-forming organs	0.000	0.998	0.002
V23.4 Driver injured in traffic accident	0.002	0.998	0.000
D72 Other disorders of white blood cells	0.000	0.998	0.002
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
D75.2 Essential thrombocytosis	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
S62.51 Fracture of thumb (open)	0.002	0.998	0.000
Q24.9 Congenital malformation of the heart, unspecified	0.002	0.998	0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system	0.000	0.998	0.002
M19.93 Arthrosis, unspecified (Forearm)	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
D74 Methaemoglobinaemia	0.000	0.998	0.002
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere	0.000	0.998	0.002
D71 Functional disorders of polymorphonuclear neutrophils	0.000	0.998	0.002
L91.0 Keloid scar	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.000	0.998	0.002
S12.20 Fracture of other specified cervical vertebra (closed)	0.002	0.998	0.000
D72.8 Other specified disorders of white blood cells	0.000	0.998	0.002
S22.00 Fracture of thoracic vertebra (closed)	0.002	0.998	0.000
S62.80 Fracture of other and unspecified parts of wrist and hand (closed)	0.002	0.998	0.000
D75.0 Familial erythrocytosis	0.000	0.998	0.001
I24.8 Other forms of acute ischaemic heart disease	0.000	0.998	0.002
J32.4 Chronic pansinusitis	0.000	0.998	0.001
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.998	0.002
Q24 Other congenital malformations of heart	0.002	0.998	0.000
D72.1 Eosinophilia	0.000	0.998	0.001
D76.3 Other histiocytosis syndromes	0.000	0.998	0.001
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
D72.9 Disorder of white blood cells, unspecified	0.000	0.998	0.001
D72.0 Genetic anomalies of leukocytes	0.000	0.998	0.001
K70.9 Alcoholic liver disease, unspecified	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
Y52.7 Peripheral vasodilators	0.001	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
D76.2 Haemophagocytic syndrome, infection-associated	0.000	0.998	0.001
D76.1 Haemophagocytic lymphohistiocytosis	0.000	0.998	0.001
D76.0 Langerhans' cell histiocytosis, not elsewhere classified	0.000	0.998	0.001
T18.1 Foreign body in oesophagus	0.000	0.998	0.002
Z36 Antenatal screening	0.000	0.998	0.002
Q24.5 Malformation of coronary vessels	0.001	0.998	0.000
Y52.1 Calcium-channel blockers	0.001	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.001	0.998	0.000
Z33 Pregnant state, incidental	0.002	0.998	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.998	0.001
D74.9 Methaemoglobinaemia, unspecified	0.000	0.998	0.001
D74.8 Other methaemoglobinaemias	0.000	0.998	0.001
D74.0 Congenital methaemoglobinaemia	0.000	0.998	0.001
I89.0 Lymphoedema, not elsewhere classified	0.000	0.998	0.001
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
Y42.4 Oral contraceptives	0.001	0.998	0.000
Y42.2 Antithyroid drugs	0.001	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.001	0.998	0.000
M46.9 Inflammatory spondylopathy, unspecified	0.001	0.999	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
M77.02 Medial epicondylitis (Upper arm)	0.001	0.999	0.000
I21.9 Acute myocardial infarction, unspecified	0.000	0.999	0.001
R47.1 Dysarthria and anarthria	0.000	0.999	0.001
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.001	0.999	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.999	0.001
Q24.6 Congenital heart block	0.001	0.999	0.000
Q24.4 Congenital subaortic stenosis	0.001	0.999	0.000
Q24.3 Pulmonary infundibular stenosis	0.001	0.999	0.000
Q24.2 Cor triatriatum	0.001	0.999	0.000
Q24.1 Levocardia	0.001	0.999	0.000
Q24.0 Dextrocardia	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
D75.1 Secondary polycythaemia	0.000	0.999	0.001
N20.0 Calculus of kidney	0.001	0.999	0.000
R29.4 Clicking hip	0.000	0.999	0.001
R29.3 Abnormal posture	0.000	0.999	0.001
R29.2 Abnormal reflex	0.000	0.999	0.001
R29.1 Meningismus	0.000	0.999	0.001
R29.0 Tetany	0.000	0.999	0.001
R47.0 Dysphasia and aphasia	0.000	0.999	0.001
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Z42.2 Follow-up care involving plastic surgery of other parts of trunk	0.000	0.999	0.001
Z80.3 Family history of malignant neoplasm of breast	0.000	0.999	0.001
E07.9 Disorder of thyroid, unspecified	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
Z87.8 Personal history of other specified conditions	0.001	0.999	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.000	0.999	0.001
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.999	0.001
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.999	0.001
O72 Postpartum haemorrhage	0.000	0.999	0.001
D75.8 Other specified diseases of blood and blood-forming organs	0.000	0.999	0.001
S06.8 Other intracranial injuries	0.001	0.999	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.001	0.999	0.000
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.001	0.999	0.000
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.001	0.999	0.000
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.001	0.999	0.000
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.001	0.999	0.000
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.001	0.999	0.000
I84.5 External haemorrhoids without complication	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.999	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.999	0.001
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.001	0.999	0.000
W20-W49 Exposure to inanimate mechanical forces	0.000	0.999	0.001
S12.2 Fracture of other specified cervical vertebra	0.001	0.999	0.000
S62.6 Fracture of other finger	0.000	0.999	0.001
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium	0.000	0.999	0.001
W44 Foreign body entering into or through eye or natural orifice	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
R06.4 Hyperventilation	0.000	0.999	0.001
W44.0 Home	0.000	0.999	0.001
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
D73 Diseases of spleen	0.000	0.999	0.001
W21 Striking against or struck by sports equipment	0.000	0.999	0.001
O72.0 Third-stage haemorrhage	0.000	0.999	0.001
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
D41.9 Urinary organ, unspecified	0.000	0.999	0.001
D41.7 Other urinary organs	0.000	0.999	0.001
D41.3 Urethra	0.000	0.999	0.001
D41.2 Ureter	0.000	0.999	0.001
D41.1 Renal pelvis	0.000	0.999	0.001
W21.9 Unspecified place	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.001	0.999	0.000
O72.3 Postpartum coagulation defects	0.000	0.999	0.001
F03 Unspecified dementia	0.000	0.999	0.001
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.001	0.999	0.000
S06.81 Other intracranial injuries (with open intracranial wound)	0.001	0.999	0.000
V23.9 Unspecified motorcycle rider injured in traffic accident	0.001	0.999	0.000
V23.5 Passenger injured in traffic accident	0.001	0.999	0.000
V23.3 Person injured while boarding or alighting	0.001	0.999	0.000
V23.2 Unspecified motorcycle rider injured in nontraffic accident	0.001	0.999	0.000
V23.1 Passenger injured in nontraffic accident	0.001	0.999	0.000
V23.0 Driver injured in nontraffic accident	0.001	0.999	0.000
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.999	0.001
I21 Acute myocardial infarction	0.000	0.999	0.001
E61.1 Iron deficiency	0.000	0.999	0.001
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.001	0.999	0.000
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.000	0.999	0.001
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations